Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 676.80
Bid: 678.10
Ask: 678.30
Change: 3.60 (0.53%)
Spread: 0.20 (0.029%)
Open: 678.60
High: 679.40
Low: 670.30
Prev. Close: 673.20
HSBA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report - 7 of 54

20 Mar 2015 16:21

RNS Number : 0674I
HSBC Holdings PLC
20 March 2015
 



Consolidated balance sheet

Five-year summary consolidated balance sheet

2014US$m

2013US$m

2012US$m

2011US$m

2010US$m

ASSETS

 

Cash and balances at central banks

129,957

166,599

141,532

129,902

57,383

Trading assets26

304,193

303,192

408,811

330,451

385,052

Financial assets designated at fair value

29,037

38,430

33,582

30,856

37,011

Derivatives

345,008

282,265

357,450

346,379

260,757

Loans and advances to banks27

112,149

120,046

117,085

139,078

141,869

Loans and advances to customers27,28

974,660

992,089

962,972

899,010

897,847

Reverse repurchase agreements - non-trading26,27

161,713

179,690

70,112

83,328

126,921

Financial investments

415,467

425,925

421,101

400,044

400,755

Other assets

161,955

163,082

179,893

196,531

147,094

Total assets at 31 December

2,634,139

2,671,318

2,692,538

2,555,579

2,454,689

LIABILITIES AND EQUITY

Liabilities

Deposits by banks27

77,426

86,507

95,480

95,205

87,221

Customer accounts27

1,350,642

1,361,297

1,311,396

1,223,140

1,190,763

Repurchase agreements - non-trading26,27

107,432

164,220

40,567

48,402

60,325

Trading liabilities26

190,572

207,025

304,563

265,192

300,703

Financial liabilities designated at fair value

76,153

89,084

87,720

85,724

88,133

Derivatives

340,669

274,284

358,886

345,380

258,665

Debt securities in issue

95,947

104,080

119,461

131,013

145,401

Liabilities under insurance contracts

73,861

74,181

68,195

61,259

58,609

Other liabilities

121,459

120,181

123,141

134,171

109,954

Total liabilities at 31 December

2,434,161

2,480,859

2,509,409

2,389,486

2,299,774

Equity

Total shareholders' equity

190,447

181,871

175,242

158,725

147,667

Non-controlling interests

9,531

8,588

7,887

7,368

7,248

Total equity at 31 December

199,978

190,459

183,129

166,093

154,915

Total liabilities and equity at 31 December

2,634,139

2,671,318

2,692,538

2,555,579

2,454,689

Five-year selected financial information

2014US$m

2013US$m

 

2012US$m

 

2011US$m

 

2010US$m

 

 

 

 

 

 

 

 

Called up share capital

9,609

9,415

 

9,238

 

8,934

 

8,843

Capital resources29,30

190,730

194,009

 

180,806

 

170,334

 

167,555

Undated subordinated loan capital

2,773

2,777

 

2,778

 

2,779

 

2,781

Preferred securities and dated subordinated loan capital31

47,208

48,114

 

48,260

 

49,438

 

54,421

Risk-weighted assets29

1,219,765

1,092,653

 

1,123,943

 

1,209,514

 

1,103,113

 

 

 

 

 

 

 

 

Financial statistics

 

 

 

 

 

 

 

 

Loans and advances to customers as a percentage ofcustomer accounts27

72.2

72.9

 

73.4

 

73.5

 

75.4

Average total shareholders' equity to average total assets

7.01

6.55

 

6.16

 

5.64

 

5.53

 

 

 

 

 

 

 

 

Net asset value per ordinary share at year-end32 (US$)

9.28

9.27

 

9.09

 

8.48

 

7.94

Number of US$0.50 ordinary shares in issue (millions)

19,218

18,830

 

18,476

 

17,868

 

17,686

 

 

 

 

 

 

 

 

Closing foreign exchange translation rates to US$:

 

 

 

 

 

 

 

 

US$1: £

0.642

0.605

 

0.619

 

0.646

 

0.644

US$1: €

0.823

0.726

 

0.758

 

0.773

 

0.748

For footnotes, see page 109.

A more detailed consolidated balance sheet is contained in the Financial Statements on page 337.

Movement in 2014

Total reported assets were US$2.6 trillion, 1% lower than at 31 December 2013. On a constant currency basis, total assets were US$85bn or 3% higher.

Our balance sheet remains strong with a ratio of customer advances to customer accounts of 72%. Although customer loans and customer accounts have fallen on a reported basis, both have increased on a constant currency basis, notably rising in Asia.

The following commentary is on a reported basis unless otherwise stated.

Assets

Cash and balances at central banks decreased by US$37bn, notably in Europe, in part reflecting net reductions in repurchase and reverse repurchase agreements.

Trading assets were broadly unchanged. Excluding adverse foreign exchange movements of US$18bn, trading assets grew, primarily from the holdings of debt securities in Asia to support GB&M's Rates business. In Europe, trading assets were broadly unchanged as increased holdings of equity securities were broadly offset by reductions in several other asset classes.

Financial assets designated at fair value decreased by US$9bn, notably in Europe, largely from the transfer to 'Assets held for sale' of balances relating to the UK Pension business of HSBC Life (UK) Limited.

Derivative assets increased by 22%, notably in Europe relating to interest rate and foreign exchange derivative contracts reflecting market movements, including changes in yield curves and foreign exchange rates.

Loans and advances to customers marginally decreased by US$17bn or 2% including adverse foreign exchange movements of US$45bn. Excluding these movements, customer lending grew by US$28bn, or 3%, largely from growth in Asia of US$32bn and, to a lesser extent, in North America and Latin America. By contrast, balances decreased in Europe by US$15bn, as term lending growth in CMB and GB&M was more than offset by a fall in corporate overdraft balances relating to a small number of customers, as explained further below.

In Asia, term lending to CMB and GB&M customers grew, which included growth in commercial real estate and other property-related lending. Mortgage balances also increased, mainly in Hong Kong. In North America, the growth in balances was driven by increased term lending to corporate and commercial customers in CMB and GB&M, partly offset by a decline in RBWM from the continued reduction in the US run-off portfolio and the transfer to 'Assets held for sale' of US first lien mortgage balances. Balances also rose in Latin America, mainly in CMB in Brazil and GB&M in Mexico.

The fall in lending in Europe of US$15bn was driven by a reduction in corporate overdraft balances. In the UK, a small number of clients benefit from the use of net interest arrangements across their overdraft and deposit positions. During the year, as we aligned our approach in our Payments and Cash Management business to be more globally consistent, many of these clients increased the frequency with which they settled these balances, reducing their overdraft and deposit balances which fell by US$28bn. Other customer loans and advances increased by US$13bn, mainly in CMB and GB&M, driven by an increase in term lending to corporate and commercial customers, notably in the second half of the year.

Reverse repurchase agreements decreased by US$18bn, driven by a managed reduction in Europe as we reassessed the overall returns of these activities in light of new regulatory requirements. This decrease was partly offset by increases in Asia and North America.

Liabilities

Repurchase agreements decreased by US$57bn or 35%, driven by a decrease in Europe, notably in the UK and France, reflecting the managed reduction in reverse repurchase agreements in Europe as noted above.

Customer accounts decreased marginally by US$11bn, and included adverse foreign exchange movements of US$58bn. Excluding these movements, balances increased by US$47bn or 4%, with growth in all regions, notably Asia, of US$36bn. The increase in Asia reflected growth in our Payments and Cash Management business in CMB and GB&M, an increase in balances in Securities Services in GB&M and a rise in RBWM, in part reflecting successful deposit campaigns. In Europe, balances increased marginally despite a US$28bn fall in corporate current accounts, mainly in GB&M, in line with the fall in corporate overdraft balances, and a reduction in client deposits in GPB. These factors were more than offset by growth in CMB and, to a lesser extent, in GB&M as deposits from our Payments and Cash Management business increased together with a rise in RBWM balances reflecting customers' continued preference for holding balances in current and savings accounts.

Trading liabilities fell by US$16bn including adverse foreign exchange movements of US$12bn. Excluding these, balances fell reflecting changes in client demand.

Financial liabilities designated at fair value reduced by US$13bn, mainly in Europe reflecting the transfer to 'Liabilities held for sale' of balances relating to the UK Pension business of HSBC Life (UK) Limited.

The increase in derivative liabilities was in line with that of 'Derivative assets' as the underlying risk is broadly matched.

 

Equity

Total shareholders' equity rose by 5%, driven by profits generated in the year, which were partially offset by dividends paid. In addition, shareholders' equity increased as we issued new contingent convertible securities of US$5.7bn during 2014. For further details of these securities, see Note 35 on the Financial Statements. These movements were partly offset by a reduction of US$9bn in our foreign exchange reserve reflecting the notable appreciation in the US dollar against sterling and the euro, particularly in the second half of the year.

 

Reconciliation of consolidated reported and constant currency assets and liabilities

 

31 December 2014 compared with 31 December 2013

 

31 Dec 13 as reported

 

Currency

translation

adjustment33

 

31 Dec 13

at 31 Dec 14

exchange

rates

 

31 Dec 14

as

reported

 

Reported

change

 

Constant

currency

change

US$m

 

US$m

 

US$m

 

US$m

 

%

 

%

 

 

 

 

 

 

 

 

 

 

 

Cash and balances at central banks

166,599

 

(9,384)

 

157,215

 

129,957

 

(22)

 

(17)

Trading assets

303,192

 

(18,176)

 

285,016

 

304,193

 

 

7

Financial assets designated at fair value

38,430

 

(2,467)

 

35,963

 

29,037

 

(24)

 

(19)

Derivative assets

282,265

 

(16,582)

 

265,683

 

345,008

 

22

 

30

Loans and advances to banks27

120,046

 

(4,923)

 

115,123

 

112,149

 

(7)

 

(3)

Loans and advances to customers27

992,089

 

(45,494)

 

946,595

 

974,660

 

(2)

 

3

Reverse repurchase agreements -non-trading26,27

179,690

 

(9,961)

 

169,729

 

161,713

 

(10)

 

(5)

Financial investments

425,925

 

(15,285)

 

410,640

 

415,467

 

(2)

 

1

Other assets

163,082

 

(385)

 

162,697

 

161,955

 

(1)

 

 

 

 

 

 

 

 

 

 

 

 

Total assets

2,671,318

 

(122,657)

 

2,548,661

 

2,634,139

 

(1)

 

3

 

 

 

 

 

 

 

 

 

 

 

 

Deposits by banks27

86,507

 

(3,317)

 

83,190

 

77,426

 

(10)

 

(7)

Customer accounts27

1,361,297

 

(57,673)

 

1,303,624

 

1,350,642

 

(1)

 

4

Repurchase agreements - non-trading26, 27

164,220

 

(7,730)

 

156,490

 

107,432

 

(35)

 

(31)

Trading liabilities

207,025

 

(12,208)

 

194,817

 

190,572

 

(8)

 

(2)

Financial liabilities designated atfair value

89,084

 

(3,930)

 

85,154

 

76,153

 

(15)

 

(11)

Derivative liabilities

274,284

 

(16,214)

 

258,070

 

340,669

 

24

 

32

Debt securities in issue

104,080

 

(5,089)

 

98,991

 

95,947

 

(8)

 

(3)

Liabilities under insurance contracts

74,181

 

(4,447)

 

69,734

 

73,861

 

 

6

Other liabilities

120,181

 

(4,221)

 

115,960

 

121,459

 

1

 

5

 

 

 

 

 

 

 

 

 

 

 

 

Total liabilities

2,480,859

 

(114,829)

 

2,366,030

 

2,434,161

 

(2)

 

3

 

 

 

 

 

 

 

 

 

 

 

 

Total shareholders' equity

181,871

 

(7,720)

 

174,151

 

190,447

 

5

 

9

Non-controlling interests

8,588

 

(108)

 

8,480

 

9,531

 

11

 

12

 

 

 

 

 

 

 

 

 

 

 

 

Total equity

190,459

 

(7,828)

 

182,631

 

199,978

 

5

 

9

 

 

 

 

 

 

 

 

 

 

 

Total liabilities and equity

2,671,318

 

(122,657)

 

2,548,661

 

2,634,139

 

(1)

 

3

For footnotes, see page 109.

 

Combined view of lending and deposits26,27

2014

2013

 

Change

US$m

US$m

 

%

Customers - amortised cost

 

 

 

Loans and advances to customers

974,660

992,089

 

(2)

Loans and advances to customers reported in 'Assets held for sale'34

577

1,703

 

(66)

Reverse repurchase agreements - non-trading

66,310

88,215

 

(25)

 

 

 

 

 

Combined customer lending

1,041,547

1,082,007

 

(4)

 

 

 

 

 

Customer accounts

1,350,642

1,361,297

 

(1)

Customer accounts reported in 'Liabilities of disposal groups held for sale'

145

2,187

 

(93)

Repurchase agreements - non-trading

79,556

121,515

 

(35)

 

 

 

 

 

Combined customer deposits

1,430,343

1,484,999

 

(4)

 

 

 

 

 

Banks - amortised cost

 

 

 

 

Loans and advances to banks

112,149

120,046

 

(7)

Reverse repurchase agreements - non-trading

95,403

91,475

 

4

 

 

 

 

 

Combined bank lending

207,552

211,521

 

(2)

 

 

 

 

 

Deposits by banks

77,426

86,507

 

(10)

Repurchase agreements - non-trading

27,876

42,705

 

(35)

 

 

 

 

 

Combined bank deposits

105,302

129,212

 

(19)

 

 

 

Customers and banks - fair value

 

 

 

Trading assets - reverse repos

1,297

10,120

 

(87)

- loans and advances to customers

908

7,180

 

(87)

- loans and advances to banks

389

2,940

 

(87)

 

 

 

 

Trading liabilities - repos

3,798

17,421

 

(78)

- customer accounts

898

9,611

 

(91)

- deposits by banks

2,900

7,810

 

(63)

For footnotes, see page 109.

Financial investments

2014

2013

Equity

securities

 

Debt

securities

 

Total

Equity

securities

 

Debt

securities

 

Total

US$bn

 

US$bn

 

US$bn

US$bn

 

US$bn

 

US$bn

-

 

 

 

 

 

 

 

 

 

Balance Sheet Management

-

 

306.8

 

306.8

-

 

314.4

 

314.4

Insurance entities

-

 

48.5

 

48.5

-

 

46.4

 

46.4

Structured entities

0.1

 

14.9

 

15.0

0.1

 

22.6

 

22.7

Principal Investments

2.0

 

-

 

2.0

2.7

 

-

 

2.7

Other

8.6

 

34.6

 

43.2

6.3

 

33.4

 

39.7

-

 

 

 

 

 

 

 

 

 

 

At 31 December

10.7

 

404.8

 

415.5

9.1

 

416.8

 

425.9

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACSJMMJTMBJTBLA
Date   Source Headline
14th Jun 20245:20 pmRNSTransaction in Own Shares
14th Jun 202411:00 amRNSIssuance of contingent convertible securities
13th Jun 20245:30 pmRNSTransaction in Own Shares
13th Jun 20247:00 amRNSIssuance of contingent convertible securities
12th Jun 20245:24 pmRNSTransaction in Own Shares
11th Jun 20245:38 pmRNSTransaction in Own Shares
11th Jun 20241:00 pmRNSFirst Interim and Special Dividend - Exchange Rate
10th Jun 20245:15 pmRNSTransaction in Own Shares
7th Jun 20245:32 pmRNSTransaction in Own Shares
6th Jun 20245:16 pmRNSTransaction in Own Shares
5th Jun 20245:44 pmRNSTransaction in Own Shares
4th Jun 20245:22 pmRNSTransaction in Own Shares
3rd Jun 20245:12 pmRNSTransaction in Own Shares
31st May 20245:23 pmRNSTransaction in Own Shares
31st May 20244:30 pmRNSTotal Voting Rights
30th May 20245:28 pmRNSTransaction in Own Shares
29th May 20245:28 pmRNSTransaction in Own Shares
29th May 20244:30 pmRNSDirector/PDMR Shareholding
28th May 20245:27 pmRNSTransaction in Own Shares
28th May 20247:00 amRNSTransaction in Own Shares
24th May 20245:38 pmRNSTransaction in Own Shares
23rd May 20245:30 pmRNSTransaction in Own Shares
22nd May 20245:23 pmRNSTransaction in Own Shares
21st May 20245:25 pmRNSTransaction in Own Shares
20th May 20245:34 pmRNSTransaction in Own Shares
20th May 20243:06 pmRNSIssuance of senior unsecured notes
17th May 20245:32 pmRNSTransaction in Own Shares
17th May 20242:30 pmRNSIssuance of senior unsecured notes
16th May 20245:23 pmRNSTransaction in Own Shares
15th May 20245:40 pmRNSTransaction in Own Shares
15th May 202411:00 amRNSResults of tender offers for four series of notes
14th May 20245:55 pmRNSPricing terms for tender offers for notes
14th May 20245:54 pmRNSTransaction in Own Shares
14th May 20248:52 amRNSHolding(s) in Company
13th May 20245:30 pmRNSTransaction in Own Shares
13th May 20249:23 amRNSHolding(s) in Company
13th May 20249:16 amRNSPre Stabilisation Notice
10th May 20245:28 pmRNSTransaction in Own Shares
10th May 202410:01 amRNSDirector/PDMR Shareholding
10th May 202410:00 amRNSOverseas Regulatory Announcement - Grant of Awards
10th May 20249:03 amRNSHolding(s) in Company
9th May 20245:36 pmRNSTransaction in Own Shares
8th May 20245:40 pmRNSTransaction in Own Shares
8th May 20247:00 amRNSHSBC tender offers for four series of notes
7th May 202410:30 amRNSHSBC Holdings plc – Share buy-back
3rd May 20243:20 pmRNSAGM poll results + changes Board+Ctte composition
3rd May 202411:06 amRNSHSBC Holdings plc - AGM Statements
1st May 20244:30 pmRNSDirector Declaration
1st May 20244:00 pmRNSPublication of base prospectus supplement
30th Apr 20244:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.